Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Artiva Biotherapeutics, Inc.

NASDAQ: ARTV · Life Sciences · 10 alerts · CIK 1817241

Share price
$3.96Close, Nov 16
Market cap
$196M
Shares outstanding
49.43MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Artiva Biotherapeutics, Inc. filings on SEC EDGAR ↗

4:05 PM ET 10-Q
Financial Results

Artiva Biotherapeutics Q3 2026 Results: Net Loss of $28.8M, Loss Widens

Artiva Biotherapeutics is undergoing a significant strategic shift, including the wind-down of its AlloNK development program and a workforce reduction to preserve capital. The company is currently evaluating strategic alternatives to maximize stockholder value while managing its remaining clinical close-out and intellectual property activities.

Key figure
Net loss $28.8M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.